Hirokazu Okada

Saitama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 140 publications

Correction: PKM2 inhibitor suppresses kidney fibrogenesis by disrupting YAP-TEAD-CCN2 transcriptional signaling following ischemia-reperfusion injury.

Correction: PKM2 inhibitor suppresses kidney fibrogenesis by disrupting YAP-TEAD-CCN2 transcriptional signaling following ischemia-reperfusion injury.

Journal: The Journal of biological chemistry

Published: May 11, 2026

B-type natriuretic peptide level reduction and its predictors following sodium-glucose cotransporter 2 inhibitor treatment in patients with diabetic kidney disease: a Japan Chronic Kidney Disease Database Extension analysis.

B-type natriuretic peptide level reduction and its predictors following sodium-glucose cotransporter 2 inhibitor treatment in patients with diabetic kidney disease: a Japan Chronic Kidney Disease Database Extension analysis.

Journal: Diabetes research and clinical practice

Published: March 26, 2026

Texture Analysis of Kidney MRI Using Diffusion-Weighted Imaging and Intravoxel Incoherent Motion for Classifying the Severity of Chronic Kidney Diseases.

Texture Analysis of Kidney MRI Using Diffusion-Weighted Imaging and Intravoxel Incoherent Motion for Classifying the Severity of Chronic Kidney Diseases.

Journal: Cureus

Published: March 07, 2026

A Case of Tubulointerstitial Nephritis With IgM-positive Plasma Cells Requiring Temporary Hemodialysis.

A Case of Tubulointerstitial Nephritis With IgM-positive Plasma Cells Requiring Temporary Hemodialysis.

Journal: Internal medicine (Tokyo, Japan)

Published: March 04, 2026

Two cases of lysozyme-induced nephropathy with varying underlying diseases: myelodysplastic syndrome and chronic myelomonocytic leukemia.

Two cases of lysozyme-induced nephropathy with varying underlying diseases: myelodysplastic syndrome and chronic myelomonocytic leukemia.

Journal: CEN case reports

Published: February 09, 2026

Sex differences in peritoneal dialysis duration and management among Japanese patients: a nationwide registry analysis.

Sex differences in peritoneal dialysis duration and management among Japanese patients: a nationwide registry analysis.

Journal: BMC nephrology

Published: January 14, 2026

Patient characteristics and treatment efficacy after switching to hypoxia-inducible factor-prolyl hydroxylase inhibitors from erythropoiesis-stimulating agents in non-dialysis-dependent chronic kidney disease patients: the Reach-J CKD cohort study.

Patient characteristics and treatment efficacy after switching to hypoxia-inducible factor-prolyl hydroxylase inhibitors from erythropoiesis-stimulating agents in non-dialysis-dependent chronic kidney disease patients: the Reach-J CKD cohort study.

Journal: BMC nephrology

Published: January 09, 2026

Design of the Japan Kidney Association-Pemafibrate Intervention for Chronic Kidney Disease patients Study (JKAPI-CKD Study).

Design of the Japan Kidney Association-Pemafibrate Intervention for Chronic Kidney Disease patients Study (JKAPI-CKD Study).

Journal: Clinical kidney journal

Published: December 19, 2025

Clinical Evaluation of the Clinical Reasoning Process of Large Language Models in Nephrology: Comparative Evaluation Study.

Clinical Evaluation of the Clinical Reasoning Process of Large Language Models in Nephrology: Comparative Evaluation Study.

Journal: JMIR formative research

Published: December 17, 2025

Impact of a Transparent Easy Nudge-Based Notification on the Follow-Up Examination Behaviors in Japanese Workers: A Controlled Experiment.

Impact of a Transparent Easy Nudge-Based Notification on the Follow-Up Examination Behaviors in Japanese Workers: A Controlled Experiment.

Journal: JMA journal

Published: December 11, 2025

Kidney and Cardiovascular Outcomes by CKD stage and etiology of CKD: A Randomly Selected Nationwide Prospective Multicenter Cohort Study in Japan (Reach-J Study).

Kidney and Cardiovascular Outcomes by CKD stage and etiology of CKD: A Randomly Selected Nationwide Prospective Multicenter Cohort Study in Japan (Reach-J Study).

Journal: American journal of nephrology

Published: December 02, 2025

PKM2 inhibitor suppresses kidney fibrogenesis by disrupting YAP-TEAD-CCN2 transcriptional signaling following ischemia-reperfusion injury.

PKM2 inhibitor suppresses kidney fibrogenesis by disrupting YAP-TEAD-CCN2 transcriptional signaling following ischemia-reperfusion injury.

Journal: The Journal of biological chemistry

Published: November 11, 2025

Showing 1-12 of 140

Last Updated: 09/26/2026